Tetrahydrocannabinol similar in efficacy & safety as placebo in improving spasticity and pain in MS
How to Cite
OrthoEvidence. Tetrahydrocannabinol similar in efficacy & safety as placebo in improving spasticity and pain in MS. ACE Report. 2018;7(10):6. Available from: https://myorthoevidene.com/AceReport/Report/10354
Effects on Spasticity and Neuropathic Pain of an Oral Formulation of delta9-Tetrahydrocannabinol in Patients With Progressive Multiple SclerosisClin Ther. 2018 Sep;40(9):1467-1482. doi: 10.1016/j.clinthera.2017.01.016
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
24 patients diagnosed with progressive multiple sclerosis (MS) experiencing pain and moderate spasticity were randomly assigned to either treatment with an oral formulation of Δ9-tetrahydrocannabinol (ECP002A) or placebo for 4 weeks. Improvements in symptoms were assessed by objective and subjective measures, and the incidence and nature of adverse events were monitored. The results demonstrated n...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE